Should I Buy NATR? NATR 2026 Analysis

Should You Buy Nature's Sunshine Products Inc (NATR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

26.330

1 Day change

0.34%

52 Week Range

26.960

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient buyer: the stock is extended/overbought (RSI ~74.7) and pushing into near-term resistance (R1 ~26.53) after a recent run.
No Intellectia edge today: AI Stock Picker and SwingMax both show no signal, so there’s no strong tactical “must-buy now” trigger.
Upside case is supported by strong recent fundamentals, but at $26.37 the risk/reward is less attractive (also trading above the latest cited Street price target of $23).

Technical Analysis

Trend is bullish: moving averages are stacked positively (SMA_5 > SMA_20 > SMA_200), indicating a sustained uptrend.
Momentum is still positive but cooling: MACD histogram is above 0 (0.153) yet “positively contracting,” suggesting upside momentum is weakening.
Overbought/extended: RSI_6 at 74.684 typically signals an overbought condition (near-term pullback/consolidation risk).
Key levels: Pivot 25.211 (first area to defend); Resistance R1 26.533 then R2 27.35; Support S1 23.89.
Pattern-based forward bias provided is slightly negative over the next week/month (-0.09% / -0.53%), which doesn’t support chasing strength today.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning/skew: Open interest put-call ratio 0.83 suggests slightly more calls than puts (mildly bullish bias).
Flow: Put volume is 0 today (volume put-call ratio 0.0) with total volume only 12 contracts—sentiment read is low-confidence due to thin trading.
Volatility: 30D IV ~75.04 vs historical vol ~35.13 (IV elevated); IV percentile 66.14 indicates options are priced for larger moves than realized history.
Liquidity/participation: Today’s option volume is ~200% of 30D average, but the base level is tiny (still thin).

Technical Summary

Sell

Buy

Positive Catalysts

- Strong latest reported quarter (2025/Q3): revenue +11.97% YoY, net income +22.71% YoY, EPS +30.43% YoY, gross margin up to 73.28% (+2.73% YoY).
- Technical backdrop remains bullish (MA stack positive; MACD still above zero).
- Next earnings: 2026-02-12 (after hours) could serve as a catalyst if growth/margins remain strong.

Neutral/Negative Catalysts

- Price is above the latest cited analyst target ($23), implying less obvious valuation upside from the Street’s published view.
- Short-term technical stretch: RSI is high and price is pressing resistance near 26.53, increasing the odds of consolidation.
- Options imply elevated expected movement (high IV), which can coincide with sharp swings.
- No supportive recent news flow in the last week; hedge fund/insider trend data is neutral (no clear accumulation signal).
- No recent politician/congress trading data available (no external “influential buyer” signal).

Financial Performance

Latest quarter: 2025/Q3.
Revenue: $128.339M, +11.97% YoY (solid top-line acceleration).
Profitability: Net income $5.334M, +22.71% YoY; EPS $0.30, +30.43% YoY (earnings growing faster than sales).
Margins: Gross margin 73.28%, up 2.73% YoY (favorable mix/pricing and operating execution signal).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Latest update (2025-11-10, DA Davidson): maintained Buy and raised price target to $23 from $21 after Q3.
Street pros view (based on provided data): Pro—improving fundamentals and conviction post-Q3; Con—current price ($26.37) is already above the cited target, reducing near-term upside per that benchmark.

2 Analyst Rating

Wall Street analysts forecast NATR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NATR is 22.5 USD with a low forecast of 22 USD and a high forecast of 23 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 26.240

Low

Averages

22.5

High

Current: 26.240

Low

Averages

22.5

High

DA Davidson

Buy

maintain

$21 -> $23

AI Analysis

2025-11-10

Reason

DA Davidson

Price Target

$21 -> $23

AI Analysis

2025-11-10

maintain

Buy

Reason

DA Davidson raised the firm's price target on Nature's Sunshine to $23 from $21 and keeps a Buy rating on the shares after its Q3 results last week. The firm is citing its increased conviction in the Nature's Sunshine story, with the quarter proving a culmination of the company's efforts to enhance value proposition to the consumer at better economics to the business, the analyst tells investors in a research note.

Canaccord

Buy

maintain

$21 -> $22

2025-08-01

Reason

Canaccord

Price Target

$21 -> $22

2025-08-01

maintain

Buy

Reason

Canaccord raised the firm's price target on Nature's Sunshine to $22 from $21 and keeps a Buy rating on the shares. The firm updated its model following strong Q2 results. The strong performance with momentum exiting the quarter led management to raise both sales and adj. EBITDA guidance for the year despite continued macro uncertainty in some markets such as Taiwan and Korea. Canaccord believes this highlights management's confidence in current trends and ability to execute on their growth strategy.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for NATR

Unlock Now

NATR Should I Buy

NATR Should I Buy

Should You Buy Nature's Sunshine Products Inc (NATR) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch